Spanish-German biotech company Sygnis Pharma has entered into a licence agreement for the distribution of a new amplification buffer with QIAGEN, a sample and assay technologies provider. This is the second agreement with QIAGEN within ...
Tags: Sygnis Pharma, Buffer to Qiagen